Company: Raymond James
Job title: Managing Director
Rahul is an equity research analyst covering healthcare and biotechnology at Raymond James with a special practice focused on the development of cannabinoid-oriented technologies. Rahul holds a PhD and MASc in biomedical engineering from the University of Toronto, and an MBA from the University of Oxford. Prior to joining Raymond James, Rahul’s roles included Equity Research Analyst—Healthcare & Biotechnology with Paradigm Capital, Director of Business Development at the Centre for Commercialization of Regenerative Medicine (CCRM), Investment Manager with the Toronto-based MaRS Investment Accelerator Fund, and Strategic Marketing Analyst with GE Healthcare’s headquarters in the U.K.
Panel Discussion: Dispelling Common Misconceptions About Biotech Funding and Applying this Understanding to Cannabinoid Pharmaceuticals 12:20 pm
day: Day Two